幽门螺杆菌的基因分型方法及其应用

近几年,有关幽门螺杆菌（ＨＰ）基因分型方法及其应用的研究取得了很大进展。基因分型方法包括：质粒分型、限制性内切酶分型（ＲＥＡ）、核糖分型、染色体ＤＮＡ脉冲场凝胶电泳（ＰＦＧＥ）分型、多聚酶链反应限制性内切酶消化（ＰＣＲ－ＲＦＬＰ）分型、任意引物ＰＣＲ（ＡＰ－ＰＣＲ）分型、ＰＣＲ单链构型多态性（ＰＣＲ－ＳＳＣＰ）分型和核苷酸序列分析等。基因分型方法广泛用于ＨＰ的研究,如基因图的构建、感染复发、耐药机     

幽门螺杆菌基因分型与胃病关系研究进展

幽门螺旋杆菌(Helicobacter pylori,Hp)已被国际癌症组织确认为胃部疾病最主要的致病因子。近年来对于Hp菌株的基因分型、流行病学和致病性等方面的研究逐步深入,越来越多的研究成果证实对Hp基因分型进行细化可为精准医疗提供依据。Hp可依照Cag A羧基末端磷酸化位点、Vac A信号区(s)中间区(m)过渡区(i)缺失区(d)和粘附因子(OMPs)进行基因分型。Hp基因型差异可导致不同毒性作用,从而引起不同临床结果和疗效预后。因此对Hp基因分型可为胃病的防治提供重要依据。本文就Hp基因分型方法、基因分型及其与胃部疾病研究进展进行如下综述。     

幽门螺杆菌毒力基因分型与相关胃病

幽门螺杆菌毒力基因是其致病的原因之一,目前已知的主要毒力基因包cagPAI,vacA,iceA,babA等,不同毒力基因分型及其结合与相关性胃疾病的关系在不同地区报道不同。对幽门螺杆菌毒力基因分型的研究有利于鉴别其毒力菌株,揭示其致病机制及为幽门螺杆菌感染的流行病学研究提供帮助。     

烧伤病房MRSA医院感染暴发的PFGE分型研究

利用表型分型和基因分型的方法解析医院感染常见致病菌——耐甲氧西林金黄色葡萄球菌(MRSA)造成医院感染暴发的可能传播途径。本实验对某医院烧伤科、ICU、肿瘤科病房内从患者和环境分离的19株MRSA,进行了16种抗生素的耐药性实验和全基因组稀有位点限制性内切酶酶切脉冲凝胶电泳(PFGE)分析,并聚类分析归纳了菌株之间的相关性。结果发现在19株MRSA中有11株属于同一个菌种A型,在这些菌株中,有8株属于相同的克隆亚型A1型,分别来自烧伤科和ICU患者以及烧伤科医生、护士的手。4株属于B型,均分离自同一烧伤病房。这暗示该医院可能存在MRSA(A型)院内感染的暴发,并且存在B型流行的潜在危险。MRSA很有可能通过医护工作人员的手及鼻腔等媒介在患者间传播。因此,加强医护人员的感染控制观念,利用灵敏、可靠且分辨率强的分型技术加强MRSA感染监控至关重要。     

幽门螺杆菌耐甲硝唑基因分型与耐药性关系研究

目的：了解幽门螺杆菌（Hp）对甲硝唑的耐药株状况,探讨耐甲硝唑基因分型与耐药性的关系。方法：分离培养Hp,以纸片扩散法检测Hp对甲硝唑的耐药性,再用PCR方法扩增甲硝唑耐药基因,用RFLP方法进行基因分型,最后比较基因型与耐药性的关系。结果：武汉地区人群Hp对甲硝唑耐药率为67％,耐药株基因型与耐药性有相关性。结论：可以以基因型鉴定Hp对甲硝唑的耐药性,此方法,稳定可靠。     

幽门螺杆菌尿素酶基因的研究进展

近年来,幽门螺杆菌的分子生物学研究取得了很大进展,而既是定植因子、又是毒力因子的幽门螺杆菌尿素酶也得到了更加深入的研究。本文就近年来幽门螺杆菌尿素酶基因的结构、转录、表达调控等方面一些新的研究进展作一综述。     

幽门螺杆菌的RFLP分型的研究

建立敏感度高、重复性好的基因分型方法,对探讨幽门螺杆菌（ＨＰ）感染的传染源、传播途径及复发原因具有重要意义。本文综合介绍了ＨＰ的限制性酶切片段长度多态性（ＲＦＬＰ）分型方法的类型、原理、优缺点及取得的主要进展。研究表明,ＨＰ感染的复发主要是由于同一菌株的复发,而不是新菌株的重新感染。     

幽门螺杆菌的iceA基因

本文主要论述幽门螺杆菌iceA基因的2个等位基因iceA1和iceA2的结构及与疾病的关系,并简要介绍iceA与cagA和vacA的相关性。     

淋病奈瑟菌基因分型进展

淋病奈瑟菌表型分型方法的局限性限制其在该菌分型方面的应用。近年来,一系列该菌基因分型方法的建立弥补了表型分型方法的不足。各种基因分型方法,如Opa分型法、Por分型法、脉冲场凝胶电泳等有着各自不同的基因分型基础、应用范围及优缺点等。本文就近年来新发展的最主要的该基因分型方法作一简要介绍。     

幽门螺杆菌临床分离株的REP-PCR分析

应用REP-PCR对来自20例单纯性胃炎和20例消化性溃疡病人的幽门螺杆菌菌株进行基因分型,并运用SAS软件进行聚类分析。结果显示这些菌株按照基因型被分为两大类,但两种来源的菌株在两大类中的比例无明显差异(P＞0.1),提示幽门螺杆菌临床分离株REP-PCR基因型与致病性之间不存在明显相关性。 REP-PCR Analysis of Helicobacter pylori Clinical Strains PENG Ying1,LU Jian-xin1,YE Si-ying2,HUANG Qing-hua2 1.Institute of Cellular and Molecular Medicine,Wenzhou Medical College,Wenzhou,Zhejiang 325027,China; 2.Department of Microbiology,Tongji Medical College,Wuhan 430030,China Abstract:Helicobacter pylori strains isolated from 20 gastritis patients and 20 peptic ulcer patients was genotyped by REP-PCR and was clustered with SAS software.These strains are devided into two categories according to their genotype.But the rate of the two sources of strain in the two categories shows no apparent difference(P＞0.1),indicating that there is no significant close relationship between the genotype and the pathogenicity. Key words：Helicobacter pylori;REP-PCR;genotype     

幽门螺杆菌毒力因子进展研究

幽门螺杆菌（Helicobacter pylori,H. pylori）是一种革兰阴性杆菌,于1893年首次从慢性活动性胃炎患者的胃黏膜活检组织中被成功分离培养,是目前所知的少数能够在人胃中生存的微生物之一。H. pylori感染不仅可引起胃炎、消化道溃疡、胃黏膜组织相关性（MALT）淋巴瘤等消化系统疾病,其所携带的毒力因子还与胃癌的发生发展有关。不同基因型的H. pylori所携带的毒力因子不同,但只有小部分的感染个体会进展为胃癌的现象。虽然目前诸如CagA、VacA、BabA和OipA等许多毒力因子都已被证明与胃癌的发生有确切关系,但其具体机制仍在进一步的研究当中。本文将主要针对H. pylori中与胃癌相关的毒力因子及其致癌机制进行简要综述,以进一步明确其在胃癌发生发展中的生物学作用。     

Progress in vaccine development against Helicobacter pylori

Based on the very high prevalence of diseases caused by Helicobacter pylori, particularly in the developing world, and the rapid emergence of antibiotic resistance among clinical isolates, there is a strong rationale for an effective vaccine against H. pylori. In this review we describe recent promising candidate vaccines and prophylactic or therapeutic immunization strategies for use against H. pylori, as well as studies to identify immune responses that are related to protection in experimental animals. We also describe identification of different types of immune responses that may be related to protection against symptoms based on comparisons of H. pylori-infected patients with duodenal ulcers or gastric cancer and asymptomatic carriers. We conclude that there is still a strong need to clarify the main protective immune mechanisms against H. pylori as well as to identify a cocktail of strong protective antigens, or recombinant bacterial strains that express such antigens, that could be administered by a regimen that gives rise to effective immune responses in humans.     

幽门螺杆菌相关miRNA与胃癌关系的研究进展

微小核糖核酸(microRNA,miRNA)是一种由内源基因编码长度约为22个核苷酸的非编码RNA,其能抑制靶基因蛋白质表达,有多种生物学功能。越来越多的研究表明,miRNA在多种肿瘤中异常表达,参与肿瘤发生、发展过程。幽门螺杆菌(Helicobacter pylori,Hp)作为胃癌的主要致病因素,可通过调节miRNA的表达,在胃癌中起促进或抑制作用。现就Hp相关miRNA在胃癌中的作用作一概述。     

Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater

For this study, we isolated Helicobacter pylori from wastewater by a series of steps beginning with immunomagnetic separation and cell culture. After Gram staining and three standard microbial tests, the 16S rRNA sequences of a total of 23 out of 37 putative H. pylori isolates were verified by PCR. Eleven H. pylori isolates were genotyped and fell into four vacA classes: those with the vacA allelic variants s1a and m1, s1b and m1, s2 and m2, or s2 and m1. Most H. pylori isolates were of the vacA s1a/m1 type, which has been shown to be associated with advanced diseases based on genotyping of H. pylori from gastric cancer patients. These results demonstrated that H. pylori survives in water and may be a potential source of H. pylori transmission, especially where water is not adequately treated.     

Helicobacter pylori 26695 基因组尺度代谢研究进展

代谢网络在代谢功能研究、生物代谢过程控制、疾病诊断分析和药物靶标设计等方面具有重要理论和实践意义。生物信息学研究利用序列同源、结构模拟、对接等手段与生化实验有效结合促进了生物体代谢网络的进一步完善。本文作者在构建幽门螺杆菌（Helicobacter pylori 26695,H.pylori 26695）代谢网络的工作基础上综合了近年来研究者对H.pylori 26695代谢通路关键酶的研究成果,并结合基因组信息,综述了H.pylori 26695特异性的重要代谢通路。本文从基因组水平阐明代谢通路与基因的关系,并详细分析了关键酶对H.pylori 26695生理的重要作用,最后探讨了重构一个连续、完整的代谢网络面临的困难及其在药物靶标设计方面的研究前景。     

幽门螺杆菌抗生素耐药机制研究进展

幽门螺杆菌(Helicobacter pylori,H.pylori)感染可引起消化性溃疡、胃粘膜相关淋巴组织淋巴瘤和胃癌。随着抗生素耐药性的问题越来越严重,耐药机制的研究也不断深入。分子检测方法,尤其是核酸检测技术,可高效、快速、准确地检测幽门螺杆菌抗生素耐药基因及突变,对幽门螺杆菌感染的临床治疗发挥重要的指导作用,同时也可对幽门螺杆菌抗生素耐药性进行大规模及时有效监控。本文讨论了关于幽门螺杆菌抗生素耐药机制并着重总结了相关耐药基因及突变。     

幽门螺杆菌基因组特征及研究进展

幽门螺杆菌是胃相关疾病：慢性胃炎、消化性溃疡、胃癌和MALT淋巴瘤的一个重要的病原体。其毒力因子包括：尿素酶、鞭毛蛋白、粘附素、细胞毒素相关蛋白和空泡毒素等,通过对全基因序列分析研究,对幽门螺杆菌的致病机制有了进一步的了解。     

Helicobacter pylori in a poultry slaughterhouse: Prevalence,genotyping and antibiotic resistance pattern

Although Helicobacter pylori (H. pylori) is a highly significant pathogen, its source remains unclear. Many people consume chicken daily as a source of animal protein worldwide; thus, hygienic methods of supplying chickens for consumption are critical for public health. Therefore, our study examined the distribution of the glmM (ureC), babA2, vacA and cagA virulence genes in H. pylori strains in chicken meat and giblets (gizzards and livers) and the resistance of the strains to various antibiotics. Ninety chicken meat, gizzard and liver samples were obtained from a semi-automatic abattoir in Sadat City, Egypt, and were cultured and preliminarily analyzed using biochemical tests. The presence of the ureC, babA2, vacA and cagA genotypes was tested for in samples positive for H. pylori by multiplex polymerase chain reaction (Multiplex-PCR). The resistance of H. pylori to various antimicrobial drugs was tested using the disc diffusion method. In total, 7 of the 90 chicken samples were positive for H. pylori (7.78%); in 3/7 (42.85%) samples, the bacteria were found in the chicken liver, while the bacteria were found in the meat in 2/7 (28.57%) and in the gizzard in 2/7 (28.57%) samples. The total prevalence of both the ureC and babA2 genes in the isolated H. pylori strains was 100%, while the prevalence of the vacA and cagA genes was 57.1% and 42.9%, respectively. The resistance of H. pylori to the antibiotics utilized in our study was 100% for streptomycin; 85.7% for amoxicillin and penicillin; 71.4% for oxytetracycline, nalidixic acid and ampicillin; 57.1% for sulfamethoxazole and erythromycin; and 42.9% for neomycin, chloramphenicol and norfloxacin. In conclusion, the chicken meat and giblets were tainted by H. pylori, with a higher occurrence of the ureC, babA2, vacA and cagA genotypes. Future investigations should investigate the resistance of H. pylori to various antimicrobial agents in Egypt.     

幽门螺杆菌外膜囊泡研究进展

幽门螺杆菌(Helicobacter pylori)被认为是引起人类胃部疾病的元凶之一。外膜囊泡(Outer Membrane Vesicles,OMVs)是由细菌外膜自发脱落而形成的囊泡状结构,其具有细菌外膜多数成分,包括外膜蛋白、多糖、脂质以及其他蛋白组分。越来越多的研究正在关注外膜囊泡在幽门螺杆菌感染、发生、发展过程中的作用。同时,研究表明幽门螺杆菌外膜囊泡作为疫苗,在防治幽门螺杆菌感染中也展现了良好的应用潜力。因此,本综述总结了目前关于幽门螺杆菌外膜囊泡组成成分的研究,并讨论了外膜囊泡在幽门螺杆菌存活和致病机制中的作用,以及外膜囊泡在幽门螺杆菌感染治疗中发挥的作用。